XML 31 R20.htm IDEA: XBRL DOCUMENT v3.24.3
Stock Compensation and Earnings (Loss) per Share
 9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Stock Compensation and Earnings (Loss) per Share Stock Compensation and Earnings (Loss) per Share
Activity related to the Company’s equity compensation, which includes the Company’s restricted stock units (“RSUs”) and performance stock units (“PSUs”), was as follows:

(in thousands, except weighted average grant price)
Number of Shares
Weighted Average Grant Price
Outstanding awards, December 31, 2023
825 $21.16 
Granted403 $20.22 
Adjustments for PSU performance
(79)$19.29 
Vested
(284)$21.93 
Forfeited(22)$20.07 
Outstanding awards, September 30, 2024
843 $20.68 

The total fair value of RSUs vested was $5.5 million during the nine months ended September 30, 2024.
Activity related to the Company’s Relative Total Shareholder Return RSUs (“RTSRs”) was as follows:

(in thousands, except weighted average grant price)
Number of Shares
Weighted Average Grant Price
Outstanding awards, December 31, 2023
293 $25.80 
Granted136 $22.30 
Adjustments for RTSR performance
(27)$34.05 
Vested
(32)$34.05 
Forfeited(16)$23.24 
Outstanding awards, September 30, 2024
354 $23.20 

The total fair value of RTSRs vested was $0.5 million during the nine months ended September 30, 2024.

Stock-based compensation expense was as follows:

 Three Months Ended
September 30,		Nine Months Ended
September 30,
(in thousands)2024202320242023
Stock compensation expense$1,566 $2,220 $8,239 $8,950 
Capitalized stock compensation(182)(176)(619)(586)
Stock compensation expense, net$1,384 $2,044 $7,620 $8,364 

As of September 30, 2024, there was $9.2 million of total unrecognized compensation cost related to non-vested RSUs and RTSRs which is expected to be recognized over weighted average period of 2.3 years.
The following table indicates the computation of basic and diluted earnings (loss) per share:

Three Months Ended
September 30,		Nine Months Ended
September 30,
(in thousands, except per share amounts)2024202320242023
Calculation of net (loss) income per share:
Loss from continuing operations$(5,304)$(183)$(22,167)$(841)
Total income from discontinued operations, net of tax41 1,776 218,728 6,290 
Net (loss) income$(5,263)$1,593 $196,561 $5,449 
Amounts attributable to common shareholders
Loss from continuing operations$(6,942)$(183)$(23,805)$(841)
Total income from discontinued operations
41 1,776 218,728 6,290 
Net (loss) income attributable to common shareholders$(6,901)$1,593 $194,923 $5,449 
Basic weighted average shares outstanding54,781 50,379 53,370 50,346 
Per share amounts attributable to common shareholders
Basic - Loss from continuing operations$(0.13)$— $(0.45)$(0.02)
Basic - Income from discontinued operations, net of tax— 0.03 4.10 0.13 
Basic net (loss) income per share$(0.13)$0.03 $3.65 $0.11 
Effect of dilutive instruments outstanding:
Basic weighted average shares outstanding54,781 50,379 53,370 50,346 
Effect from dilutive shares and options outstanding— — — — 
Diluted weighted average shares outstanding54,781 50,379 53,370 50,346 
Diluted - Loss from continuing operations$(0.13)$— $(0.45)$(0.02)
Diluted - Income from discontinued operations, net of tax— 0.03 4.10 0.13 
Diluted net (loss) income per share$(0.13)$0.03 $3.65 $0.11 

The Company determines the dilutive impact of equity awards and the Series A Preferred Stock (on an as-converted basis) by applying the treasury stock method and the if-converted method, respectively. There were approximately 423,000 and 373,000 potentially dilutive equity awards during the three and nine months ended September 30, 2024, respectively; however, these shares were excluded from the calculation of diluted weighted average shares outstanding due to the fact that they were anti-dilutive as a result of the Company's loss from continuing operations for the periods. There were also approximately 3,373,000 potentially dilutive shares related to the Series A Preferred Stock (on an as-converted basis) during both the three and nine months ended September 30, 2024; however, these shares were excluded from the calculation of diluted weighted average shares outstanding due to the fact that they were anti-dilutive as a result of the Company’s loss from continuing operations for the periods. There were approximately 457,000 and 277,000 potentially dilutive equity awards during the three and nine months ended September 30, 2023, respectively; however, these shares were excluded from the calculation of diluted weighted average shares outstanding due to the fact that they were anti-dilutive as a result of the Company's loss from continuing operations for the periods.